Cargando…

Absence of vaccine-enhanced RSV disease and changes in pulmonary dendritic cells with adenovirus-based RSV vaccine

The development of a vaccine against respiratory syncytial virus (RSV) has been hampered by the risk for vaccine-enhanced RSV pulmonary disease induced by immunization with formalin-inactivated RSV (FIRSV). This study focuses on the evaluation of vaccine-enhanced pulmonary disease following immuniza...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krause, Anja, Xu, Yaqin, Ross, Sara, Wu, Wendy, Joh, Ju, Worgall, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166937/ https://www.ncbi.nlm.nih.gov/pubmed/21801372 http://dx.doi.org/10.1186/1743-422X-8-375

Ejemplares similares

Adenovirus-Based Vaccine with Epitopes Incorporated in Novel Fiber Sites to Induce Protective Immunity against Pseudomonas aeruginosa
por: Sharma, Anurag, et al.
Publicado: (2013)

Pre-Clinical Development of an Adenovirus Vector Based RSV and Shingles Vaccine Candidate
por: Petherbridge, Lawrence, et al.
Publicado: (2023)

Neonatal Genetic Delivery of Anti-Respiratory Syncytial Virus (RSV) Antibody by Non-Human Primate-Based Adenoviral Vector to Provide Protection against RSV
por: Gomi, Rika, et al.
Publicado: (2018)

1633. Willingness to receive maternal RSV vaccine and infant monoclonal RSV antibody
por: Gidengil, Courtney, et al.
Publicado: (2023)

RSV A2-Based Prefusion F Vaccine Candidates Induce RSV A and RSV B Cross Binding and Neutralizing Antibodies and Provide Protection against RSV A and RSV B Challenge in Preclinical Models
por: Cox, Freek, et al.
Publicado: (2023)

Respiratory Viruses: Influenza, RSV, and Adenovirus in Kidney Transplantation()()
por: Hawkinson, Dana J., et al.
Publicado: (2016)

Is it RSV?
por: Ambrose, Christopher S.
Publicado: (2018)

Transcriptomic response and immunological responses to chimpanzee adenovirus- and MVA viral-vectored vaccines for RSV in healthy adults
por: Green, C, et al.
Publicado: (2023)

2770. Intrapulmonary Vaccination with an M Protein-Deficient Respiratory Syncytial Virus (RSV) Vaccine Protects Infant Baboons Against an RSV Challenge
por: Welliver, Robert C, et al.
Publicado: (2019)

M Protein-Deficient Respiratory Syncytial Virus (RSV) Vaccine Protects Infant Baboons Against RSV Challenge
por: Welliver, Robert C, et al.
Publicado: (2017)

Global molecular diversity of RSV – the “INFORM RSV” study
por: Langedijk, Annefleur C., et al.
Publicado: (2020)

Current Insights in the Development of Efficacious Vaccines Against RSV
por: Soto, Jorge A., et al.
Publicado: (2020)

Viruses, vaccinations and RSV: Exploring terminology in paediatric virology
por: Mammas, Ioannis N., et al.
Publicado: (2020)

Adjuvant Selection for Influenza and RSV Prefusion Subunit Vaccines
por: Isaacs, Ariel, et al.
Publicado: (2021)

Cytokine response to the RSV antigen delivered by dendritic cell-directed vaccination in congenic chicken lines
por: Mucksová, Jitka, et al.
Publicado: (2017)

Safety and Immunogenicity of a Live Attenuated RSV Vaccine in Healthy RSV-Seronegative Children 5 to 24 Months of Age
por: Malkin, Elissa, et al.
Publicado: (2013)

A Recombinant MVA-Based RSV Vaccine Induces T-Cell and Antibody Responses That Cooperate in the Protection Against RSV Infection
por: Endt, Kathrin, et al.
Publicado: (2022)

ChAd155-RSV vaccine is immunogenic and efficacious against bovine RSV infection-induced disease in young calves
por: de Jong, Rineke, et al.
Publicado: (2022)

Safety and immunogenicity of novel respiratory syncytial virus (RSV) vaccines based on the RSV viral proteins F, N and M2-1 encoded by simian adenovirus (PanAd3-RSV) and MVA (MVA-RSV); protocol for an open-label, dose-escalation, single-centre, phase 1 clinical trial in healthy adults
por: Green, C A, et al.
Publicado: (2015)

RSV Replication, Transmission, and Disease Are Influenced by the RSV G Protein
por: Bergeron, Harrison C., et al.
Publicado: (2022)

2592. Lung Function as an Indicator of Vaccine Enhanced RSV Disease in Cotton Rats
por: Jones, Crystal, et al.
Publicado: (2019)

Preclinical evaluation of bacterially produced RSV-G protein vaccine: Strong protection against RSV challenge in cotton rat model
por: Fuentes, Sandra, et al.
Publicado: (2017)

Strategic priorities for respiratory syncytial virus (RSV) vaccine development
por: Anderson, L.J., et al.
Publicado: (2013)

Immunogenicity of RSV F DNA Vaccine in BALB/c Mice
por: Eroglu, Erdal, et al.
Publicado: (2016)

Biology of Infection and Disease Pathogenesis to Guide RSV Vaccine Development
por: Boyoglu-Barnum, Seyhan, et al.
Publicado: (2019)

2321. Long-term immunogenicity of Ad26.RSV.preF/RSV preF protein vaccine against RSV in a phase 2b study by age and risk level
por: Comeaux, Christy A, et al.
Publicado: (2022)

Vaccination against RSV: Is maternal vaccination a good alternative to other approaches?
por: Kaaijk, Patricia, et al.
Publicado: (2013)

Vaccine-induced antibody Fc-effector functions in humans immunized with a combination Ad26.RSV.preF/RSV preF protein vaccine
por: Bartsch, Yannic C., et al.
Publicado: (2023)

An outbreak of RSV infections in a neonatology clinic during the RSV-season
por: Vakrilova, Liliya, et al.
Publicado: (2021)

Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B
por: Hause, Anne M., et al.
Publicado: (2017)

Erratum: Airway T cells protect against RSV infection in the absence of antibody
por: Kinnear, E, et al.
Publicado: (2017)

Correction: Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B
por: Hause, Anne M., et al.
Publicado: (2017)

Phase 1/2a Safety and Immunogenicity of an Adenovirus 26 Vector Respiratory Syncytial Virus (RSV) Vaccine Encoding Prefusion F in Adults 18–50 Years and RSV-Seropositive Children 12–24 Months
por: Stuart, Arabella S V, et al.
Publicado: (2022)

Safety and Immunogenicity of the Respiratory Syncytial Virus Vaccine RSV/ΔNS2/Δ1313/I1314L in RSV-Seronegative Children
por: Karron, Ruth A, et al.
Publicado: (2020)

Phase 2b Study of an Ad26.RSV.preF Vaccine for Prevention of RSV-mediated Respiratory Tract Disease in Older Adults
por: Falsey, Ann, et al.
Publicado: (2021)

An RSV Live-Attenuated Vaccine Candidate Lacking G Protein Mucin Domains Is Attenuated, Immunogenic, and Effective in Preventing RSV in BALB/c Mice
por: Roe, Molly K, et al.
Publicado: (2022)

RSV awareness, risk perception, causes, and terms: Perspectives of pregnant and lactating women in Kenya to inform demand generation efforts for maternal RSV vaccines
por: Limaye, Rupali J., et al.
Publicado: (2023)

Protection of calves by a prefusion-stabilized bovine RSV F vaccine
por: Zhang, Baoshan, et al.
Publicado: (2017)

RSV Vaccine Based on Rhabdoviral Vector Protects after Single Immunization
por: Wilmschen, Sarah, et al.
Publicado: (2019)

In vitro model for the assessment of human immune responses to subunit RSV vaccines
por: Chirkova, Tatiana, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5strc6hqnta6t6pm6dp2ltkkpi